CCR2 and cancer: On the one hand, its abnormally high expression attracts immunosuppressive cells such as CCR2+ TAMs through chemotaxis, activates pro-cancer pathways such as PI3K/AKT and NF-κB, and induces EMT, directly promoting tumor invasion and metastasis[ (10).